No Association Between IRS2 Gly1057Asp Polymorphism and Esophageal Cancer
Open Access
- 30 December 2021
- journal article
- research article
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 298-303
Abstract
Introduction: The aim of this study was to figure out the relationship between IRS2 Gly1057Asp variant and susceptibility to esophageal cancer. Material and Methods: A case-control study was conducted to select 70 esophageal cancer patients and 100 healthy control samples. Genomic DNA was extracted from peripheral whole blood samples and real time polymerase chain reaction (RT-PCR) based SNP genotyping was performed using predesigned Taqman assay. Results: There was no significant difference in the frequency distribution of genotypes between patients and control group. Conclusion: There is no significant correlation between the IRS2 Gly1057Asp variant and the risk of esophageal cancer.Keywords
This publication has 22 references indexed in Scilit:
- IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumorsCancer Letters, 2013
- IRS2 is a candidate driver oncogene on 13q34 in colorectal cancerInternational Journal of Experimental Pathology, 2013
- Insulin receptor substrate-2 gene polymorphism: is it associated with endometrial cancer?Gynecological Endocrinology, 2010
- Insulin Receptor Substrates (IRSs) and Breast TumorigenesisJournal of Mammary Gland Biology and Neoplasia, 2008
- Divergent Roles for IRS-1 and IRS-2 in Breast Cancer MetastasisCell Cycle, 2007
- Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2Molecular and Cellular Biology, 2006
- Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular CarcinomaThe American Journal of Pathology, 2005
- Involvement of Insulin Receptor Substrate 2 in Mammary Tumor MetastasisMolecular and Cellular Biology, 2004
- The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancerCarcinogenesis, 2004
- Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2003